CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- 4 Other acquisition Executive Vice President & CFO acquired 37 shares (code L)
- 4 Other acquisition SVP, Clinical Solutions acquired 21 shares (code L)
- 4 Other acquisition SVP for Diagnostic Services acquired 60 shares (code L)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes SVP of Molecular Gen & Oncol gave up 120 shares (to pay taxes)
- 4 Open-market sale SVP & General Counsel sold 32,551 shares at $154.97 ($5,044,516)
- 4 Open-market sale SVP, Clinical Solutions sold 1,990 shares at $153.26 ($304,990)
- 4 Shares withheld for taxes SVP, Clinical Solutions gave up 74 shares (to pay taxes)
- 4 Open-market sale SVP & Chief Commercial Officer sold 420 shares at $143.08 ($60,094)
- 4 Other acquisition Executive Vice President & CFO acquired 21 shares (code L)
- 4 Other acquisition SVP, Clinical Solutions acquired 31 shares (code L)
- 4 Other acquisition SVP for Diagnostic Services acquired 60 shares (code L)
- 4 Other acquisition Director acquired 77 shares (code L)
- 4 Shares withheld for taxes Executive Vice President & CFO gave up 3,910 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,482 shares (grant or award)
- 4 Grant or award Director acquired 1,482 shares (grant or award)
- 4 Grant or award Director acquired 1,482 shares (grant or award)
- 4 Grant or award Director acquired 1,482 shares (grant or award)
- 4 Grant or award Director acquired 1,482 shares (grant or award)
Page 10 of 74 · 1,466 filings